Intellia Therapeutics (NASDAQ:NTLA) Earnings History and Estimates Chart
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Intellia Therapeutics (NASDAQ:NTLA) Earnings Estimates
2019 EPS Consensus Estimate: ($2.15)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2019 | 4 | ($0.62) | ($0.48) | ($0.53) |
| Q2 2019 | 4 | ($0.65) | ($0.48) | ($0.54) |
| Q3 2019 | 4 | ($0.69) | ($0.43) | ($0.53) |
| Q4 2019 | 4 | ($0.79) | ($0.44) | ($0.56) |
Intellia Therapeutics (NASDAQ NTLA) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | GAAP EPS | Revenue Estimate | Actual Revenue | Conference Call | Details |
|---|
10/30/2019
(Estimated) | | | | | | | | |
| 8/1/2019 | Q2 2019 | ($0.61) | ($0.56) | ($0.56) | $7.15 million | $11.10 million | Listen | |
| 5/2/2019 | Q1 2019 | ($0.53) | ($0.49) | ($0.49) | $9.43 million | $10.43 million | N/A | |
| 2/27/2019 | Q4 2018 | ($0.55) | ($0.43) | ($0.43) | $9.92 million | $7.90 million | N/A | |
| 10/31/2018 | 9/30/2018 | ($0.48) | ($0.53) | ($0.53) | $11.58 million | $7.41 million | N/A | |
| 8/1/2018 | Q2 2018 | ($0.55) | ($0.52) | ($0.52) | $6.39 million | $7.68 million | N/A | |
| 5/1/2018 | Q1 2018 | ($0.5770) | ($0.51) | ($0.51) | $6.14 million | $7.47 million | N/A | |
| 3/14/2018 | Q4 2017 | ($0.45) | ($0.61) | ($0.61) | $8.84 million | $6.70 million | N/A | |
| 10/31/2017 | Q3 2017 | ($0.4960) | ($0.44) | ($0.44) | $5.83 million | $7.30 million | N/A | |
| 8/3/2017 | Q2 2017 | ($0.4150) | ($0.45) | ($0.45) | $5.83 million | $5.90 million | N/A | |
| 5/2/2017 | Q1 2017 | ($0.34) | ($0.3640) | ($0.36) | $5.30 million | $6.22 million | N/A | |
| 3/14/2017 | Q4 2016 | ($0.21) | ($0.3060) | ($0.31) | $5.63 million | $5.63 million | N/A | |
| 11/1/2016 | Q3 2016 | ($0.22) | ($0.22) | ($0.22) | $4.55 million | $4.90 million | N/A | |
| 8/4/2016 | Q2 2016 | ($0.10) | ($0.36) | ($0.36) | $6.34 million | $4.21 million | N/A | |
(Earnings results data provided by Zacks Investment Research)
